House Bill 323 – Meningococcal and Shingles Vaccines

Posted in Latest News on March 30, 2018.

House Bill 323 became law on July 1, 2014 as Chapter 2014-113, Laws of Florida. This law amended section 465.189, F.S., authorizing pharmacists to administer meningococcal and shingles vaccines under certain circumstances.

On April 12, 2018, amended rule 64B16-27.630, FAC, will become effective adding the Zoster Vaccine Recombinant, Adjuvanted to the immunizations or vaccines which may be administered by a Florida licensed pharmacist. Zoster Vaccine Recombinant, Adjuvanted is the proper name of the Shingrix® vaccine developed by GlaxoSmithKline.1 Shingrix® has been recommended by the CDC, and has been added to the Adult Immunization Schedule, effective February 2018. 2

1https://www.gsksource.com/pharma/content/gsk/source/us/en/brands/shingrix/pi/home.html

2https://www.cdc.gov/vaccines/schedules/hcp/adult.html



More Latest News

First Quarterly Performance Report Released for the 2017-2018 Fiscal Year
April 15, 2018

The Quarterly Performance Report for the first quarter of the 2017-2018 fiscal year is now available online. Continue reading


House Bill 323 – Meningococcal and Shingles Vaccines
March 30, 2018

Click here for more information on authorization for pharmacists to administer meningococcal and shingles vaccines under certain circumstances. Continue reading